CGEN
Compugen Ltd.
CGEN's fundamentals are strong: revenue more than tripled and its operating margin went from −89% to 41%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CGEN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CGEN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CGEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.5x | $2.09 | -1.3% |
| Current | 5.7x | $2.12 | — |
| Fair | 6.5x | $2.48 | +17% |
| Expensive | 8x | $3.04 | +43% |
Historical ranges are pointers, not guarantees.
CGEN's PE is 5.7x, but its earnings don't support one, so it isn't a reliable read right now.
CGEN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| -- | |
| Limited | |
| Low |
Analysts expect CGEN's losses to grow, with revenue declining. However, they disagree widely on these estimates.
CGEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.38 | +$0.59 |
| Q1 2026 | $0.37 | +$0.53 |
| Q4 2025 | $0.37 | +$0.53 |
| Q3 2025 | -$0.30 | -1600% |
| Q2 2025 | -$0.21 | -$0.11 |
| Q1 2025 | -$0.16 | +$0.03 |
| Q4 2024 | -$0.16 | +$0.06 |
| Q3 2024 | $0.02 | +$0.39 |
CGEN has returned to profit: it earned $0.38 per share over the past year, after losing money the year before.
CGEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.6M | +107% |
| Q1 2026 | $2.2M | -4.7% |
| Q4 2025 | $67.3M | +4477% |
| Q3 2025 | $1.9M | -89% |
| Q2 2025 | $1.3M | -81% |
| Q1 2025 | $2.3M | -11% |
| Q4 2024 | $1.5M | -96% |
| Q4 2023 | $33.5M | +346% |
CGEN's revenue is growing: $3M last quarter, up 107% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -340% | +331 points |
| Q1 2026 | -414% | -47 points |
| Q4 2025 | 83% | +592 points |
| Q3 2025 | -417% | -444 points |
| Q2 2025 | -671% | -620 points |
| Q1 2025 | -368% | -36 points |
| Q4 2024 | -509% | -563 points |
| Q3 2024 | 26% | N/A |
CGEN's operating margin was −340% last quarter, up 331 points from the same quarter a year ago.
CGEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
CGEN's free cash flow was $0 over the past year, against $0 the year before.
CGEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +84.5K shares |
| 1 year | +1.2% | +1.1M shares |
| 3 years | +8.6% | +7.5M shares |
| 5 years | +13% | +10.8M shares |
| Available history | +45% | +29.2M shares |
CGEN has 95M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CGEN hasn't bought back shares in the past year.
CGEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
CGEN has more cash than debt.
CGEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.8 | Neutral |
| Stochastic | 14.3 | Oversold |
CGEN's weekly RSI is 46 (neutral) and its Stochastic is 14 (oversold).
CGEN PE vs Healthcare Sector
| Metric | CGEN | Sector median | Relative |
|---|---|---|---|
| PE | 5.7x | 26x | 78% below |
| PE % | 21 | 29 | 8 pts below |
CGEN is trading at 5.7x earnings, a 78% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
CGEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.10 | 1% above |
| 20 week MA | $2.30 | 7.8% below |
| 50 week MA | $2.20 | 3.6% below |
| 100 week MA | $1.92 | 10% above |
| 200 week MA | $1.69 | 25% above |
CGEN's trend is mixed: it's above three of its five weekly moving averages, and 25% above its 200-week average.
CGEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.16 | $13.1 | +113% |
| 2021 | $13.1 | $4.56 | -65% |
| 2022 | $4.56 | $0.76 | -83% |
| 2023 | $0.76 | $1.98 | +161% |
| 2024 | $1.98 | $1.57 | -21% |
| 2025 | $1.57 | $1.54 | -1.9% |
| 2026 YTD | $1.54 | $2.12 | +38% |
CGEN's yearly returns have swung widely, from +161% in 2023 to −83% in 2022. It's up 38% so far in 2026.